ArticleFrontiers in clinical diabetes and healthcare2025
Construction and effectiveness of a pharmacist-involved diabetes management model between tertiary hospitals and community under the hierarchical medical system.
Article in Frontiers in clinical diabetes and healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Feasibility of peer-assisted interprofessional learning between pharmacy and exercise physiology students in providing integrated care.BMC medical education · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study constructed a tertiary hospital-community health service center diabetes linkage management model with the participation of clinical pharmacists, assessed the changes in clinical indicators and medication treatment of patients with type 2 diabetes before and after the implementation of the model, and evaluated the model, with a view to providing a model reference in the participation of clinical pharmacists in the management of type 2 diabetes and other chronic diseases. Given the current situation that diabetes management at the community level in China is still unsatisfactory, with an HbA1c control rate of less than 10% compared to about 50% in tertiary hospitals, there is an urgent need to explore innovative, pharmacist-involved models to bridge this gap. Methods: Using the principle of randomization, patients who met the enrollment criteria were divided into the experimental group and the control group. A total of 210 patients were enrolled from three community health service centers in Nanjing in collaboration with Drum Tower Hospital, and were followed up for 12 months. Clinical indicators and medication adherence were used as evaluation endpoints to compare the differences in management effects between the two groups. This study was registered with the Chinese Clinical Trial Registry (ChiCTR2300074444). Results: Under the diabetes linkage management model, patients in the intervention group showed improvement in blood glucose, glycated hemoglobin and other indicators compared with the control group; the medication adherence score of patients in the intervention group was significantly higher than that of the control group. Conclusion: The clinical efficacy and medication level of diabetic patients were significantly improved after management by this management model, which provides a reference for clinical pharmacists to carry out pharmacy services in the context of hierarchical diagnosis and treatment. This model may contribute to narrowing the quality gap between tertiary hospitals and community health service centers in diabetes care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.